BalchemvsLinde

BCPC and LIN stock compared: price, dividend, valuation and results, from SEC filings.

Balchem (BCPC) has a market value of $5.5B and Linde (LIN) $245B. Over the last year, with dividends, BCPC moved +11.2% and LIN +26.3%. The P/E is 32.5 for BCPC and 34.9 for LIN. Dividend yield: BCPC none, LIN 1.19%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BCPC$5.5B

    LIN$245B

    LIN is 44 times BCPC

  • Revenue, 12 months

    BCPC$1.1B

    LIN$36.2B

    LIN is 33 times BCPC

  • Net income, 12 months

    BCPC$171M

    LIN$7.0B

    LIN is 41 times BCPC

  • Operating margin

    BCPC20.7%

    LIN25.3%

    4.6 points apart

  • ROIC

    BCPC13.8%

    LIN11.1%

    2.7 points apart

  • P/E

    BCPC32.5

    LIN34.9

    LIN is 1.1 times BCPC

  • Dividend yield

    BCPC0.0%

    LIN1.2%

    1.2 points apart

  • 5-year return

    BCPC+8.3%

    LIN+69.0%

    60.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BCPC+8.3%

LIN+69.0%

10015020222023202420252026
Returns by period
PeriodBCPCWith dividendsLINWith dividends
1 year since November 14, 2025+11.2%Price +10.5%+26.3%Price +24.6%
3 years since November 16, 2023+42.0%+12.4% a yearPrice +39.7%+34.3%+10.3% a yearPrice +29.2%
5 years since November 15, 2021+8.3%+1.6% a yearPrice +5.5%+69.0%+11.1% a yearPrice +58.0%
10 years since November 16, 2016+133.5%+8.9% a yearPrice +121.5%+431.5%+18.2% a yearPrice +350.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BCPCBalchemLINLinde

Valuation

BCPCLIN
Valuation
Price$173.20$527.97
Market value$5.5B$245B
Enterprise value (EV)$5.6B$266B
P/E32.534.9
P/E, 5-year median41.532.6
P/B4.26.2
EV/EBIT24.429.0
Free cash flow yield3.2%2.1%

Results and growth

BCPCLIN
Results and growth
Revenue, 12 months$1.1B$36.2B
Net income, 12 months$171M$7.0B
Free cash flow, 12 months$178M$5.1B
Earnings per share, 12 months$5.31$15.06
Revenue growth, year on year8.8%3.0%
Revenue growth a year, past+8.1%over 5 years+4.5%over 5 years
EPS growth a year, past+12.8%over 5 years+25.4%over 5 years

Margins and returns on capital

BCPCLIN
Margins and returns on capital
Gross margin36.5%47.9%
Operating margin20.7%25.3%
Net margin15.4%19.3%
ROIC13.8%11.1%
ROE13.2%18.1%

Balance sheet

BCPCLIN
Balance sheet
Cash$66M$3.9B
Total debt$142M$25.2B
Net debt / EBITDA0.21.7
Interest cover–35.5×

Dividends and buybacks

BCPCLIN
Dividends and buybacks
Dividend yield–1.2%
Dividend per share, 12 months–$6.30
Dividend growth a year, past+11.1%over 5 years+9.3%over 5 years
Buyback yield1.9%1.9%
Shareholder yield1.9%3.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BCPC or LIN

Didn't find what you were looking for?

Ask us
Which is bigger, Balchem or Linde?

By market value, Linde ($245B) is about 44.1 times Balchem ($5.5B), at today's prices.

How did BCPC and LIN stock do over the last 10 years?

Since November 16, 2016, BCPC's price moved +121.5% and LIN's +350.5%. With dividends: BCPC +133.5% (+8.9% a year), LIN +431.5% (+18.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, BCPC or LIN?

The dividend yield at today's price is none for Balchem and 1.19% for Linde. Over the last twelve months they paid – and $6.30 per share.

What is the P/E of BCPC and LIN?

At today's price, the P/E is 32.5 for BCPC and 34.9 for LIN. The median of the last five years was 41.5 and 32.6, which shows where each stands against its own past.

Which has the higher profit margins, Balchem or Linde?

Over the last twelve months, the net margin was 15.4% for Balchem and 19.3% for Linde, and the operating margin 20.7% and 25.3%. Revenue was $1.1B and $36.2B.

Which is the better investment, Balchem or Linde?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.